BERKELEY, Calif.--(BUSINESS WIRE)--IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced its second FDA authorization, securing 510(k) clearance from ...
Despite patients sharing a usual interstitial pneumonia (UIP) pattern on lung CT scans, patients with connective tissue disease-related interstitial lung disease (CTD-ILD) demonstrated a slower ...
EULAR—The European Alliance of Associations for Rheumatology—has worked with the European Respiratory Society (ERS) to develop new clinical practice guidelines for interstitial lung disease (ILD) ...
Current noninvasive tests for PH in ILD patients lack accuracy and validation, highlighting an unmet need for better diagnostic tools. Artificial intelligence could improve PH diagnosis in ILD, ...
Conventional wisdom holds that the longer a patient has rheumatoid arthritis (RA), the greater their risk for interstitial lung disease (ILD), but a recent analysis from a long-term study has provided ...
IMVARIA's ScreenDx enhances referral pathways by automatically assessing medical data for interstitial lung findings compatible with interstitial lung disease (ILD) BERKELEY, Calif.--(BUSINESS ...
EULAR - The European Alliance of Associations for Rheumatology - has worked with the European Respiratory Society (ERS) to develop new clinical practice guidelines for interstitial lung disease (ILD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback